Tulu Koota Kuwait to donate kidney dialysis units to Adarsha, SCS hospitals

March 20, 2011
Mangalore, March 20: Tulukoota Kuwait in association with Aadarsha hospital Udupi is holding the "Tulukoota Kuwait Kidney Dialysis Project".


A recent survey has indicated that less than 10% of the total patients requiring dialysis in India are able to avail the facility. Hemodialysis treatment is very expensive. The medicines are equally costly and a majority of the patients are not able to afford this treatment. Adding to the problem, health insurance policies do not cover the cost of dialysis owing to the high cost.



As part of Tulukoota Kuwait Kidney Dialysis Project, the Koota has decided to donate a kidney dialysis unit to Adarsha hospital Udupi, the formal programme for which would be held on Friday, March 25, at the hospital.




Similarly the Koota has decided to donate two kidney dialysis units and RO Plant to SCS Hospital Mangalore where BPL (below poverty line) patients & lower income group patients will be entitled to receive free/discounted kidney dialysis. The formal programme with regard to this will be held on Sunday, March 27 at the hospital.

AS_0

AS_1

Comments

Doctor Mansi
 - 
Wednesday, 9 May 2018

Greeting from Narayana Hospital India,We are urgently in need of K1dney donors ([email protected]) Doctor Mansi WhatsApp no: (+917899056482)

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 12,2020

Mangalore, Jan 12: City police on Sunday arrested five people for their alleged involvement in a Rs 50 crore fraud by promising people higher monetary returns.

Police said that the arrested persons are Manjunath Nayak, a resident of Derebail; Denzil Mascarenhas, a Konchady resident; Ashok Naik, a Derebail resident; Vikas Nayak and Vishwanath Naik both residents of Bengaluru were arrested.

The arrested were employed in the ‘Speak and Group’ concern, started by Dhanush M K of Kundapur along with his friends. The firm had managed to collect huge sums of money from people, including NRIs by promising monthly four percent returns on their investment. The employees managed to entice people by showing them a few insurance schemes claiming higher returns.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
July 28,2020

Mangaluru, July 28: In an unexpected development, the government of Karnataka has transferred Dakshina Kannada Deputy Commissioner Sindhu B Rupesh.

The development comes days after the IAS officer warned of legal action against those attacking cattle traders in the region.

Another IAS officer Dr Rajendra K V who was the CEO of Belagavi Zilla Panchayat, has been transferred and posted as the new Deputy Commissioner of Dakshina Kannada.

Dr Rajendra is a medical doctor graduated from Bapuji Medical College, Davangere. He had secured the 32nd rank in the civil services examination in 2013.

Sindhu B Rupesh had taken over as DK DC in September 2019.  Now, she is posted as the director, electronic delivery citizen services (EDCS), DP & AR (e governance) Bengaluru.

Also Read: Death threat against DK DC Sindhu B Rupesh after she warns against attack on cattle traders

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.